Total Visits

Views
Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients1

Total Visits Per Month

July 2019August 2019September 2019October 2019November 2019December 2019January 2020
Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients0000001

File Visits

Views
Stokke2018_Article_Pre-dosingWithLilotomabPriorTo.pdf1

Top country views

Views
United States1

Top cities views

Views
Mountain View1